Riskpilot← Back to searchSign inGet full accessBudolfi-Høreklinik ApS
APSActiveCVR 33502621Strandparken 48Other human health activities n.e.c. · NACE 8699Est. 20112 employees
Revenue 2024
DKK 582K
+1732% vs 2023
EBITDA margin
-5.8%
-207% vs 2023
Equity ratio
20.5%
Financial strength
Net profit 2024
DKK -28K
-219% vs 2023
| Revenue | DKK 582K | +1732% |
| EBITDA | DKK -34K | -207% |
| Net profit | DKK -28K | -219% |
| Total assets | DKK 399K | +57% |
| Equity | DKK 82K | -26% |
| Employees | 2 | — |
Legal name
Budolfi-Høreklinik ApS
CVR number
33502621
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
21. februar 2011
Share capital
DKK 90.300
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med høreklinik og salg af høreapparater og høreforbedringsteknologi til hørehæmmede samt anden dermed beslægtet virksomhed.
Address
Strandparken 48
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 315 | 196 | 791 | 1.263 | 1.142 | 1.198 | 1.249 | 945 | 680 | 1.175 | 430 | 32 | 582 |
| Staff expenses | -192 | -167 | -166 | -473 | -766 | -743 | -608 | -657 | -888 | -703 | -466 | -0 | -615 |
| EBITDA | 100 | 3 | 599 | 765 | 376 | 455 | 641 | 289 | -208 | 472 | -36 | 31 | -34 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -20 | -3 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 100 | 3 | 599 | 765 | 356 | 452 | 641 | 289 | -208 | 472 | -36 | 31 | -34 |
| Net financials | -31 | -13 | -11 | -3 | 2 | -2 | -1 | -0 | -4 | -2 | -2 | -1 | -3 |
| Profit before tax | 69 | -10 | 588 | 762 | 358 | 450 | 640 | 288 | -211 | 469 | -38 | 31 | -36 |
| Tax | 17 | 6 | 138 | 180 | 79 | 101 | 141 | 63 | -46 | 103 | -8 | 7 | -8 |
| Net profit | 51 | -16 | 450 | 582 | 279 | 348 | 499 | 225 | -165 | 366 | -30 | 24 | -28 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 698 | 290 | 532 | 1.028 | 700 | 566 | 1.082 | 839 | 987 | 994 | 409 | 254 | 399 |
| Equity | — | -129 | 322 | 694 | 373 | 262 | 590 | 315 | 150 | 516 | 86 | 110 | 82 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54 | 55 | 57 |
| Short-term debt | 810 | 418 | 209 | 335 | 327 | 303 | 492 | 524 | 837 | 478 | 269 | 88 | 260 |
| Total debt | 810 | 418 | 211 | 335 | 327 | 303 | 492 | 524 | 837 | 478 | 322 | 144 | 318 |
EBITDA margin
-5.8%
This company
15.8%
Market median
-137% vs market
20122024
Equity ratio
20.5%
This company
38.2%
Market median
-46% vs market
20122024
Return on equity
-34.8%
This company
18.4%
Market median
-289% vs market
20122024
Net profit margin
-4.9%
This company
8.1%
Market median
-160% vs market
20122024
Asset turnover
1.46×
This company
1.12×
Market median
+30% vs market
20122024
Debt / equity
3.88×
This company
0.62×
Market median
-526% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HT Management | Management | 2021 | — | — |
HJ Management | Management | 2011 | — | — |
PS Management | Management | 2011 | — | — |
GH Management | Management | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BUDOLFI HØREKLINIK ApS | Company | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPECIALLÆGESELSKABET MIKKEL ATTERMANN BRUHN ApSBUDOLFI HØREKLINIK ApS
Budolfi-Høreklinik ApS (this company)Board members of Budolfi-Høreklinik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Thestrup Kock | Management | 0 companies |
| Hanne Jessen | Management | 0 companies |
| Per-Henrik Schønherr Christensen | Management | 0 companies |
| Grethe Harbo | Management | 0 companies |
| Pascal Antoine Bonvin | Board of Directors | 0 companies |
| Peder Christian Frandsen | Board of Directors | 0 companies |
| Mikkel Attermann Bruhn | Chairman | 0 companies |
| Janus Bo Bechmann Jespersen | Board of Directors | 0 companies |